San Francisco headquartered Burrill & Company has completed a Series B round of financing of US$10 million in Strand Life Sciences, a Bangalore-based life sciences company that develops data analysis and visualization software for microarray gene expression data. Burrill & Company is a diversified global financial services firm focused on the life sciences industry with US$1.5 billion assets under management. The financing included both, a primary investment into Strand and a secondary buy-out of the lead Series A investors, WestBridge Capital and Ascent Capital.

Majmudar & Partners’ Bangalore partner, N. Raja Sujith, acted for Burrill & Company. Strand was represented by Trilegal partner, Kosturi Ghosh, and WestBridge Capital by AZB & Partners’ Srinath Dasari.